glp 1 agonist shortage Shortages improve for Lilly's GLP-1 weight loss drugs, bumping sales forecast by $3bn GLP-1 Receptor Agonist Market Growth

Description

Supplementary information Rights and permissions Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made

[DOI] [PMC free article] [PubMed] [Google Scholar] 30.Marso S.P., Bain S.C., Consoli A., Eliaschewitz F.G., Jdar E., Leiter L.A., Lingvay I., Rosenstock J., Seufert J., Warren M.L., et al

Cancer, aging and an unknown number of other changes can ensue

The interaction of GLP-1 with its receptor leads to an increase in intracellular cAMP levels and activation of numerous cellular processes that vary depending on the organ or system involved [5]